Letter: Rifaximin versus low FODMAP diet in IBS: What the primary endpoint does not tell us. Authors' reply
Chuah, Kee Huat, Loo, Qing Yuan, Loh, Audrey Joe Chii, Leong, Jing Yi, Chan, Wah Loong, Khoo, Xin Hui, Wong, Kim Leng, Panirsheeluam, Sarala, Natarajan, Vicraman, Ng, Ai Kah, Majid, Hazreen Abdul and Mahadeva, Sanjiv (2026) Letter: Rifaximin versus low FODMAP diet in IBS: What the primary endpoint does not tell us. Authors' reply. Alimentary Pharmacology & Therapeutics, 63. pp. 909-910. ISSN 1365-2036
![[img]](https://hsu.repository.guildhe.ac.uk/style/images/fileicons/text.png) |
Text (Article details)
Majid H 2026 APT 2 Cover Sheet.pdf - Other Available under License All Rights Reserved . Download (62kB) |
Official URL: https://doi.org/10.1111/apt.70553
| Item Type: | Article |
|---|---|
| Schools: | School of Health and Rehabilitation Sciences |
| Depositing User: | Jessica Tovey |
| Date Deposited: | 15 May 2026 10:31 |
| Last Modified: | 15 May 2026 11:12 |
| URI: | https://hsu.repository.guildhe.ac.uk/id/eprint/630 |
Actions (login required)
 |
Edit Item |